Clemastine is an antihistamine with anticholinergic and sedative effects. Antidepressants with anticholinergic properties may worsen hallucinations and delusions. Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. Treatment includes both a pralidoxime binder and an anticholinergic such as atropine. Most antihistamines exhibit some type of anticholinergic activity. Amantadine may affect the central nervous system due to dopaminergic and anticholinergic properties. Tiotropium is a muscarinic receptor antagonist, often referred to as an antimuscarinic or anticholinergic agent. Chlorprothixene has a strong sedative activity with a high incidence of anticholinergic side effects. Benzatropine is a centrally acting anticholinergic/antihistamine agent. It does not have the acetylecholine side effect commonly seen in an anticholinergic antispasmodic. Amantadine is another treatment option due to its dopaminergic and anticholinergic effects. Amantadine may be used alone or combined with another anti-parkinson or anticholinergic drug. It is in the anticholinergic and antihistamine family of medications. Paralytic ileus is commonly seen as a result of anticholinergic toxicity. This commonly includes a combination of a short-acting inhaled beta agonist and anticholinergic.